Merck & Co., Inc. (MRK) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Merck & Company, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.478 Thank you for standing by. Welcome to the Merck and Company Incorporated, Rathway, New 00:00:04.478 -- 00:00:09.045 Jersey, USA, Quarter One Sales and Earnings Conference Call. 00:00:09.045 -- 00:00:12.450 At this time, all participants are in listening mode until the question and answer session 00:00:12.450 -- 00:00:14.393 of today's conference. 00:00:14.393 -- 00:00:18.500 At that time, to ask a question, press star one on your phone to record your name at 00:00:18.500 -- 00:00:22.927 the prompt. This call is being recorded. If you have any objections, you may disconnect 00:00:22.927 -- 00:00:27.093 at this time. I would like to turn the call over to Mr. 00:00:27.093 -- 00:00:30.102 Dannenbaum. Senior Vice President, Investor Relations. 00:00:30.102 -- 00:00:30.983 Sir, you may begin. 00:00:30.983 -- 00:00:32.445 Thank 00:00:32.445 -- 00:00:37.191 you, Dustin, and good morning, everyone. Welcome to the first quarter 2025 conference 00:00:37.191 -- 00:00:41.797 call for Merck and Company Incorporated, Rahway, New Jersey, USA. 00:00:41.797 -- 00:00:46.242 Speaking on today's call will be Rob Davis, Chairman and Chief Executive Officer, Caroline 00:00:46.242 -- 00:00:48.645 Litchfield, Chief Financial Officer, and Dr. 00:00:48.645 -- 00:00:53.439 Dean Lee, President of Research Labs. Before we get started, I'd like to point out that 00:00:53.439 -- 00:00:57.464 we have items in our GAAP results, such as acquisition-related charges, restructuring 00:00:57.464 -- 00:01:01.629 costs, and certain other items that we have excluded from our non-GAAP results. 00:01:01.629 -- 00:01:04.533 There is a reconciliation in our press release. 00:01:04.533 -- 00:01:07.597 I will also remind you that some of the statements that we make today may be ...